Post of the Day: Here's shares O/S from two years for BMOD compared to shares O/S today......Everyone has to admit the BMOD team did an incredible job of keeping shares issued in check. Two years later, an entire FDA trial under their belt and barely a 20% increase in shares O/S during that two year period. Throw in virtually no debt on BMOD's books now. This is how you do it the right way for your shareholders.
Compare that to RPC who went from 36 million shares o/s to 156 million o/s overnight when they issued 120 million free trading shares to pay off their massive debts in one shot and collapsed their share price. Crazy part is, even now RPC still has no FDA trials even started while BMOD is about to announce the results of their completed FDA trial yet RPC still has triple BMOD's market cap. Not for long though, BMOD express about to roll right on by.
The number of issuer’s shares of Common Stock outstanding as of March 15, 2009 was 77,004,589 shares
The number of issuer’s shares of Common Stock outstanding as of March 15, 2011, was 92,936,886 shares.
